Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer

BACKGROUND: The current standard of care for patients with unresectable locally advanced non-small cell lung cancer (NSCLC) is chemoradiotherapy (CRT) combined with durvalumab consolidation therapy. However, radiotherapy (RT) always carries the risk of radiation pneumonitis (RP), which can preclude...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakagami, Mai, Inokuchi, Haruo, Mukumoto, Nobutaka, Itoyama, Hiroshige, Hamaura, Nobunari, Yamagishi, Mutsumi, Mukumoto, Naoki, Matsuda, Shogo, Kabata, Daijiro, Shibuya, Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204233/
https://www.ncbi.nlm.nih.gov/pubmed/37217919
http://dx.doi.org/10.1186/s13014-023-02276-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204233/
https://www.ncbi.nlm.nih.gov/pubmed/37217919
http://dx.doi.org/10.1186/s13014-023-02276-7

Ejemplares similares